Sector Watch: Healthcare - Mar 28 2019
This is an archive page. To See the most recent Healthcare Sectorwatch click here
IBB: $109.46 +0.66 0.61% | XBI: $88.89 +1.13 1.29% | Updated Mar 28, 2019 04:26 PM
| HEALTHCARE STOCKS - TOP GAINERS | ||||
|---|---|---|---|---|
| SNSS Sunesis Pharmaceuticals $80.4M |
1.19+0.18 899.1 K |
18% | ||
| NTRA Natera $1.3B |
19.95+1.77 582.2 K |
10% | ||
| GTHX G1 Therapeutics $613.1M |
16.39+1.29 684.7 K 2.4x |
9% | ||
| EYEN Eyenovia $68.1M |
5.78+0.43 185.6 K |
8% | ||
| ATRA Atara Biotherapeutics $1.8B |
38.64+2.86 363.9 K |
8% | ||
| HEALTHCARE STOCKS - TOP LOSERS | ||||
|---|---|---|---|---|
| ARA52WL American Renal Associates Holdings Inc $195.4M |
6.01-3.70 2.8 M 16.0x |
-38% | ||
| EYPT Eyepoint Pharmaceuticals $168.8M |
1.77-0.44 3.5 M 12.8x |
-20% | ||
| AVEO AVEO Pharmaceuticals $96.5M |
0.69-0.14 17.0 M 3.5x |
-16% | ||
| VSTM Verastem $216.4M |
2.93-0.24 3.6 M |
-8% | ||
| NBRV Nabriva Therapeutics AG $166.6M |
2.39-0.19 889.7 K |
-7% | ||
Not for trading - Data delayed up to 20 minutes from last update time.
Excludes companies with market caps below $50M.
Market Caps next to company names. Trading volumes below stock prices.
NNx - unusual volume NN times the 3-month avg. volume
52WL - 52-week Low in this trading session
52WH - 52-week High in this trading session
Healthcare Stocks Related News
Class Action Alert CAG, DPLO & AVEO Bronstein, Gewirtz & Grossman, LLC [globenewswire.com]Glancy Prongay & Murray LLP Announces Investigation on Behalf of American Renal Associates Holdings, Inc. Investors | Business Wire [businesswire.com]
EyePoint Pharmaceuticals Announces Pricing of Public Offering of Common Stock [globenewswire.com]
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vanda Pharmaceuticals, AVEO Pharmaceuticals, Stamps.com, and Syneos and Encourages Investors to Contact the Firm [globenewswire.com]
Kaskela Law LLC Announces Investigation of American Renal Associates Holdings, Inc. on Behalf of Investors ? ARA [globenewswire.com]
AMERICAN RENAL (ARA) RESTATEMENT INVESTIGATION: Rosen Law Firm Continues to Investigate Securities Claims Against American Renal Associates Holdings, Inc.; Encourages Investors to Contact the Firm ? ARA | Business & Finance | manchestertimes.com [businesswire.com]
American Renal Associates Investigated by Block & Leviton LLP For Violations of Federal Securities Laws [globenewswire.com]
EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock [globenewswire.com]
American Renal Associates Holdings, Inc. Provides Update on Audit Committee Review and Announces Organizational Changes | Business Wire [businesswire.com]
CLASS ACTION UPDATE for UXIN, AVEO, AMRN and AMR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders [globenewswire.com]
Eyenovia Reports Fourth Quarter and Full Year 2018 Financial Results [globenewswire.com]
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against AVEO Pharmaceuticals, Inc. (AVEO) and Encourages AVEO Investors to Contact the Firm [globenewswire.com]
AVEO: Zhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against AVEO Pharmaceuticals Inc.? AVEO - GlobeNewswire [globenewswire.com]
CareDx Files Patent Infringement Lawsuit Against Natera [globenewswire.com]
AMERICAN RENAL INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates American Renal Associates Holdings, Inc. for Possible Securities Fraud - ARA | Business Wire [businesswire.com]
CLASS ACTION UPDATE for AVEO, STMP, AMR and MBT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders [globenewswire.com]
HIIQ, AVEO & CVS Bronstein, Gewirtz & Grossman, LLC Class Action Reminder [globenewswire.com]
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of SPB, ASTE, VALE and AVEO [globenewswire.com]
Class Action Update KHC, AVEO & CVS Bronstein, Gewirtz & Grossman, LLC - GlobeNewswire [globenewswire.com]
Disclaimer Red Acre Investments is not a registered investment advisor and the views and opinions offered herein do not constitute investment advice. Investors should always conduct their own due diligence before trading. You should assume that Red Acre is trading the securities mentioned in our Red Acre Insights, generally in accordance with the views we express, although our positions may change as news evolves. We do not undertake any obligation to update our views as market conditions evolve.
